Akèy › Maladi kadyovaskilè › Pennsylvania › Lancaster
Etid klinik pou Maladi kadyovaskilè nan Lancaster, PA
5 etid pou Maladi kadyovaskilè ap chèche patisipan nan sit nan ak bò kote Lancaster (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
ELEVATE-HFpEF Clinical Study
Ap rekrite
- Lancaster General Hospital, Lancaster
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Ap rekriteFaz 4
- Penn Lancaster General Health Research Institute, Lancaster
Product Surveillance Registry
Ap rekriteEtid obsèvasyon
- Lancaster, Lancaster
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Ap rekriteFaz 3
- Lancaster General Health, Lancaster
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Ap rekrite
- Penn Medicine Lancaster General Health, Lancaster
Etid Maladi kadyovaskilè nan lòt vil
- Boston, MA37 etid
- New York City, NY33 etid
- Washington, DC29 etid
- Houston, TX24 etid
- Dallas, TX23 etid
- Atlanta, GA22 etid
- Cleveland, OH22 etid
- Chicago, IL21 etid
- Philadelphia, PA21 etid
- Pittsburgh, PA20 etid
- St. Louis, MO20 etid
- San Francisco, CA18 etid
Lòt etid nan Lancaster
- Kansè Poumon ki pa ti selil7 etid
- Ensifizyans kadyak5 etid
- Kansè pwostat4 etid
- Kansè Metastatik4 etid
- Kansè nan tete4 etid
- Kansè poumon3 etid
- Kansè vejik3 etid
- Amblyopi3 etid
- Maladi kè3 etid
- Kansè Vezik ki pa envazif miskilè3 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.